GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $462,000 | -54.7% | 14,454 | -50.9% | 0.03% | -18.2% |
| Q1 2022 | $1,020,000 | -50.3% | 29,454 | -41.1% | 0.03% | -92.0% |
| Q4 2018 | $2,053,000 | -24.7% | 50,000 | -17.1% | 0.41% | -62.5% |
| Q2 2018 | $2,726,000 | +22.1% | 60,300 | -0.5% | 1.09% | +65.6% |
| Q1 2017 | $2,233,000 | – | 60,598 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |